180 related articles for article (PubMed ID: 21851336)
1. Receptor-isoform-selective insulin analogues give tissue-preferential effects.
Vienberg SG; Bouman SD; Sørensen H; Stidsen CE; Kjeldsen T; Glendorf T; Sørensen AR; Olsen GS; Andersen B; Nishimura E
Biochem J; 2011 Dec; 440(3):301-8. PubMed ID: 21851336
[TBL] [Abstract][Full Text] [Related]
2. Differential gene expression of insulin receptor isoforms A and B and insulin receptor substrates 1, 2 and 3 in rat tissues: modulation by aging and differentiation in rat adipose tissue.
Serrano R; Villar M; Martínez C; Carrascosa JM; Gallardo N; Andrés A
J Mol Endocrinol; 2005 Feb; 34(1):153-61. PubMed ID: 15691885
[TBL] [Abstract][Full Text] [Related]
3. 18F9 (4-(3,6-bis (ethoxycarbonyl)-4,5,6,7-tetrahydrothieno (2,3-c) pyridin-2-ylamino)-4-oxobutanoic acid) enhances insulin-mediated glucose uptake in vitro and exhibits antidiabetic activity in vivo in db/db mice.
Anandharajan R; Sayyed SG; Doshi LS; Dixit P; Chandak PG; Dixit AV; Brahma MK; Deshmukh NJ; Gupte R; Damre A; Suthar J; Padigaru M; Sharma SD; Nemmani KV
Metabolism; 2009 Oct; 58(10):1503-16. PubMed ID: 19608207
[TBL] [Abstract][Full Text] [Related]
4. The effects of brain-derived neurotrophic factor on insulin signal transduction in the liver of diabetic mice.
Tsuchida A; Nakagawa T; Itakura Y; Ichihara J; Ogawa W; Kasuga M; Taiji M; Noguchi H
Diabetologia; 2001 May; 44(5):555-66. PubMed ID: 11380073
[TBL] [Abstract][Full Text] [Related]
5. Use of high affinity insulin analogues to assess the functional relationships between insulin receptor trafficking, mitogenic signaling and mRNA expression in rat liver.
Authier F; Merlen C; Amessou M; Danielsen GM
Biochimie; 2004 Mar; 86(3):157-66. PubMed ID: 15134829
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of insulin receptors in rat tissues as detected with the partial agonist B29,B29'-suberoyl-insulin.
Breiner M; Weiland M; Becker W; Müller-Wieland D; Streicher R; Fabry M; Joost HG
Mol Pharmacol; 1993 Aug; 44(2):271-6. PubMed ID: 8355664
[TBL] [Abstract][Full Text] [Related]
7. N-3 polyunsaturated fatty acids prevent the defect of insulin receptor signaling in muscle.
Taouis M; Dagou C; Ster C; Durand G; Pinault M; Delarue J
Am J Physiol Endocrinol Metab; 2002 Mar; 282(3):E664-71. PubMed ID: 11832371
[TBL] [Abstract][Full Text] [Related]
8. Human aortic smooth muscle cells are insulin resistant at the receptor level but sensitive to IGF1 and IGF2.
Chisalita SI; Johansson GS; Liefvendahl E; Bäck K; Arnqvist HJ
J Mol Endocrinol; 2009 Dec; 43(6):231-9. PubMed ID: 19589910
[TBL] [Abstract][Full Text] [Related]
9. Different effects of IGF-I on insulin-stimulated glucose uptake in adipose tissue and skeletal muscle.
Frick F; Oscarsson J; Vikman-Adolfsson K; Ottosson M; Yoshida N; Edén S
Am J Physiol Endocrinol Metab; 2000 Apr; 278(4):E729-37. PubMed ID: 10751208
[TBL] [Abstract][Full Text] [Related]
10. A polyphenol rescues lipid induced insulin resistance in skeletal muscle cells and adipocytes.
Gogoi B; Chatterjee P; Mukherjee S; Buragohain AK; Bhattacharya S; Dasgupta S
Biochem Biophys Res Commun; 2014 Sep; 452(3):382-8. PubMed ID: 25157809
[TBL] [Abstract][Full Text] [Related]
11. Insulin analogues with modifications at position B26. Divergence of binding affinity and biological activity.
Záková L; Kazdová L; Hanclová I; Protivínská E; Sanda M; Budesínský M; Jirácek J
Biochemistry; 2008 May; 47(21):5858-68. PubMed ID: 18452310
[TBL] [Abstract][Full Text] [Related]
12. Insulin and IGF-I action on insulin receptors, IGF-I receptors, and hybrid insulin/IGF-I receptors in vascular smooth muscle cells.
Johansson GS; Arnqvist HJ
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1124-30. PubMed ID: 16803852
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of the multiple insulin and insulin receptor mRNAs by somatostatin.
Caruso MA; Sheridan MA
Mol Cell Endocrinol; 2014 Mar; 384(1-2):126-33. PubMed ID: 24486191
[TBL] [Abstract][Full Text] [Related]
14. Effects of a new hypoglycemic agent A-4166 on glucose metabolism in rat adipocytes and muscle tissues.
Macho L; Ficková M; Zórad S; Seböková E; Klimes I
Gen Physiol Biophys; 1999 Sep; 18(3):293-303. PubMed ID: 10703745
[TBL] [Abstract][Full Text] [Related]
15. Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats.
Kramer D; Shapiro R; Adler A; Bush E; Rondinone CM
Metabolism; 2001 Nov; 50(11):1294-300. PubMed ID: 11699047
[TBL] [Abstract][Full Text] [Related]
16. Receptor binding and biological potency of despentapeptide insulin.
Taylor R; Hetherington CS; Tolley S
Horm Metab Res; 1989 May; 21(5):249-52. PubMed ID: 2673959
[TBL] [Abstract][Full Text] [Related]
17. Myricetin, a naturally occurring flavonol, ameliorates insulin resistance induced by a high-fructose diet in rats.
Liu IM; Tzeng TF; Liou SS; Lan TW
Life Sci; 2007 Nov; 81(21-22):1479-88. PubMed ID: 17976658
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at adipocytes.
Müller G; Geisen K
Horm Metab Res; 1996 Sep; 28(9):469-87. PubMed ID: 8911985
[TBL] [Abstract][Full Text] [Related]
19. Age-related changes in insulin receptor mRNA and protein expression in genetically obese Zucker rats.
Amessou M; Tahiri K; Chauvet G; Desbuquois B
Diabetes Metab; 2010 Apr; 36(2):120-8. PubMed ID: 20149705
[TBL] [Abstract][Full Text] [Related]
20. Insulin glargine is more potent in activating the human IGF-I receptor than human insulin and insulin detemir.
Varewijck AJ; Goudzwaard JA; Brugts MP; Lamberts SW; Hofland LJ; Janssen JA
Growth Horm IGF Res; 2010 Dec; 20(6):427-31. PubMed ID: 21055982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
